# JB Therapeutics, Inc. — Form D

JB Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-10. The offering totals $1.5M, of which $662K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2012-04-10
- Form: D
- Accession: 0001546588-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $662K
- Remaining: $838K
- Minimum investment: $10K
- Investors: 26
- Date of first sale: 2012-04-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-176436

## Issuer

- Name: JB Therapeutics, Inc.
- CIK: 0001546588
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 508 DUDLEY ROAD, NEWTON, MA, 02459
- Phone: 617-244-3885

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Peter Aranow | Director | Waltham, MA |
| Jeff Arnold | Director | San Francisco, CA |
| Sumner Berstein | Director | Framingham, MA |
| Mark Tepper | Director | Newton, MA |
| Mark Tepper | Executive Officer | Newton, MA |

## More

- [CIK 1546588 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1546588&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001546588-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.